Multiple endocrine neoplasia type 1 historical perspective

Jump to navigation Jump to search

Multiple endocrine neoplasia type 1 Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Multiple endocrine neoplasia type 1 from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Multiple endocrine neoplasia type 1 historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Multiple endocrine neoplasia type 1 historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Multiple endocrine neoplasia type 1 historical perspective

CDC on Multiple endocrine neoplasia type 1 historical perspective

Multiple endocrine neoplasia type 1 historical perspective in the news

Blogs on Multiple endocrine neoplasia type 1 historical perspective

Directions to Hospitals Treating Multiple endocrine neoplasia type 1

Risk calculators and risk factors for Multiple endocrine neoplasia type 1 historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [3]

Overview

Multiple endocrine neoplasia type 1 was first described by Dr.Erdheim, a German physician, in 1903 by reporting a case of an acromegalic patient with pituitary adenoma and three enlarged parathyroid glands.

Historical Perspective

The following table describes the major historically significant events about multiple endocrine neoplasia type 1.

MEN I Historical Background
Years Scientist Contribution
1903 Erdheim Reported case of an acromegalic patient with pituitary adenoma and three enlarged parathyroid glands.
1953 Underdahl Reported case series of patients with syndrome of pituitary, parathyroid, and pancreatic islet adenomas.
1954 Wermer Identified that multiple endocrine neoplasia was transmitted as a dominant trait.
1962 Williams and Celestin First described bronchial carcinoid as a feature of multiple endocrine neoplasia type 1.
1963 Jacobs and Underwood Reported case of hypoglycemia and islet cell adenomas in 3 members of the family, with father having hyperparathyroidism and broncial carcinoma and son and daughter with idiopathic epilepsy [1].
1966 Guida Identified pituitary adenoma and duodenal carcinoid in patients with multiple endocrine neoplasia type 1 syndrome [2].
1967 Johnson Presented a multiple endocrine neoplasia type 1 case devoid of peptic ulcer [3].
1968 Steiner Introduced the term "multiple endocrine neoplasia" (MEN) to describe disorders featuring combinations of endocrine tumors and proposed the terms 'Wermer syndrome' for multiple endocrine neoplasia type 1 and 'Sipple syndrome' for multiple endocrine neoplasia type 2.
1972 Vance Suggested the importance of primary genetic lesion in endocrine adenomatosis in developing neoplasia and hyperfunctioning of islet of langerhans [4].
1982 McCarthy Identified 2 different causes of Zollinger-Ellison syndrome, malignant type and the one linked with multiple endocrine neoplasia type 1 [5].
1983 Hershon Identified family members from Pacific Northwest with prolactinomas but with no pancreatic tumors.
1985 Bear Referred the disorders reported from Burin as multiple endocrine neoplasia type 1 Burin.
1986 Brandi Suggested the humoral cause of primary hyperparathyroidism in familial multiple endocrine neoplasia type 1.
1986 Schimke Suggested a 2 step model of pathogenesis which include germline mutation followed by somatic mutation later.
1986 Bahn Identified 25 year old monozygotic twins with one having primary hyperparathyroidism, Zollinger-Ellison syndrome, cushing's disease, and hyperprolactinemia and the other have primary hyperparathyroidism and hyperprolactinemia [6].
1986 Maton Identified that cushing's syndrome is more common with Zollinger-Ellison syndrome [7].
1988 The multiple endocrine neoplasia type 1 locus was assigned to chromosome 11 (11q13).
1993 Gaitan Described mother and daughter with cushing's disease due to ACTH secreting tumor [8].
1994 Petty Identified that gene involved in Pacific Northwest studies and Burin studies linked to 11q chromosome.
1997 Darling Suggested that one of the diagnostic findings of multiple endocrine neoplasia type 1 is cutaneous manifestations.
1998 The multiple endocrine neoplasia type 1 gene was cloned [9].
1999 Yu Identified that gastrinoma growth is the single most important factor in deciding the long term survival of patients with Zollinger-Ellison syndrome [10].
2001 Bordi Identified patients with multiple endocrine neoplasia syndrome to have carcinoid tumors [11].

References

  1. UNDERWOOD LE, JACOBS NM (1963). "FAMILIAL ENDOCRINE ADENOMATOSIS. A FAMILY WITH HYPERINSULINISM AS THE PREDOMINANT MANIFESTATION". Am J Dis Child. 106: 218–23. PMID 14056823.
  2. Guida PM, Todd JE, Mooe SW, Beal JM (1966). "Zollinger-Ellison syndrome with interesting variations. Report of twelve cases including one of carcinoid of the duodenum". Am J Surg. 112 (6): 807–17. PMID 4288594.
  3. Johnson GJ, Summerskill WH, Anderson VE, Keating FR (1967). "Clinical and genetic investigation of a large kindred with multiple endocrine adenomatosis". N Engl J Med. 277 (26): 1379–85. doi:10.1056/NEJM196712282772601. PMID 4384073.
  4. [1] MULTIPLE ENDOCRINE NEOPLASIA, TYPE I; MEN1
  5. McCarthy DM (1982). "Zollinger-Ellison syndrome". Annu Rev Med. 33: 197–215. doi:10.1146/annurev.me.33.020182.001213. PMID 7044271.
  6. Bahn RS, Scheithauer BW, van Heerden JA, Laws ER, Horvath E, Gharib H (1986). "Nonidentical expressions of multiple endocrine neoplasia, type I, in identical twins". Mayo Clin Proc. 61 (9): 689–96. PMID 2875227.
  7. Maton PN, Gardner JD, Jensen RT (1986). "Cushing's syndrome in patients with the Zollinger-Ellison syndrome". N Engl J Med. 315 (1): 1–5. doi:10.1056/NEJM198607033150101. PMID 2872593.
  8. Gaitan D, Loosen PT, Orth DN (1993). "Two patients with Cushing's disease in a kindred with multiple endocrine neoplasia type I." J Clin Endocrinol Metab. 76 (6): 1580–2. doi:10.1210/jcem.76.6.8099078. PMID 8099078.
  9. Guru SC, Manickam P, Crabtree JS, Olufemi SE, Agarwal SK, Debelenko LV. Identification and characterization of the multiple endocrine neoplasia type 1 (MEN1) gene. J Intern Med 243(6) 433-9
  10. Yu F, Venzon DJ, Serrano J, Goebel SU, Doppman JL, Gibril F; et al. (1999). "Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome". J Clin Oncol. 17 (2): 615–30. PMID 10080607.
  11. Bordi C, Corleto VD, Azzoni C, Pizzi S, Ferraro G, Gibril F; et al. (2001). "The antral mucosa as a new site for endocrine tumors in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndromes". J Clin Endocrinol Metab. 86 (5): 2236–42. doi:10.1210/jcem.86.5.7479. PMID 11344233.

Template:WS Template:WH